Table: Pharmarise Holdings -2016/17 group results

Pharmarise Holdings

14/07/2017 10:10

Jul 14 (Reuters)-  
          Pharmarise Holdings Corp  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT     
                May 31, 2017    May 31, 2016   May 31, 2018     YEAR       
                   LATEST         YEAR-AGO        COMPANY       COMPANY    
                   RESULTS         RESULTS       FORECAST     H1 FORECAST  
  Sales             52.95           48.51          54.60         27.30     
                 (+9.1 pct)      (+22.8 pct)    (+3.1 pct)    (+8.2 pct)   
  Operating        442 mln         813 mln          1.02        475 mln    
                 (-45.5 pct)     (-28.9 pct)   (+129.2 pct)  (+177.6 pct)  
  Recurring        324 mln         659 mln        890 mln       410 mln    
                 (-50.8 pct)     (-33.9 pct)   (+174.5 pct)  (+233.6 pct)  
  Net 
  Net               7 mln          382 mln        205 mln       85 mln     
                 (-98.0 pct)     (+67.7 pct)                               
  EPS             0.85 yen        42.44 yen      22.68 yen     9.40 yen    
  EPS Diluted     0.83 yen        41.55 yen                                
  Ann Div         14.00 yen       14.00 yen      14.00 yen                 
  -Q2 Div            NIL             NIL            NIL                    
  -Q4 Div         14.00 yen       14.00 yen      14.00 yen                 
   
  NOTE - Pharmarise Holdings Corp. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T 
  ((Tokyo Headline News Desk +813 6441 1812))